The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLX.L Regulatory News (FLX)

  • There is currently no data for FLX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of the Placing and Total Voting Rights

4 May 2017 12:02

RNS Number : 2083E
Falanx Group Limited
04 May 2017
 

THIS ANNOUNCEMENT, INCLUDING THE INFORMATION INCLUDED IN IT, IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO FROM, OR TO PERSONS IN, THE UNITED STATES OF AMERICA ("UNITED STATES"), AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF IRELAND AND THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO UNLESS PERMITTED PURSUANT TO AN EXEMPTION UNDER THE RELEVANT LOCAL LAW OR REGULATION IN ANY SUCH JURISDICTION. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN AND SHALL THEREFORE CEASE TO BE INSIDE INFORMATION.

 

THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFERING OF, OR SOLICITATION TO PURCHASE OR SUBSCRIBE, SECURITIES IN THE COMPANY.

 

 

Falanx Group Limited

("Falanx" or "the Company")

 

Results of the Placing and Total Voting Rights

 

Falanx Group Limited (AIM: FLX) a cyber defence and intelligence provider working with blue chip, SME and government clients worldwide, is pleased to announce that the proposed placing announced this morning (the "Placing") was oversubscribed. A total of 29,090,909 new ordinary shares in the Company (the "Placing Shares") were successfully placed with investors at a price of 6.875 pence per Placing Share, raising £2 million before expenses.

 

Turner Pope Investments will receive, as placing agent for the subscription, 545,455 Ordinary Shares as fees, which are subject to a 6 month 'Lock-in' period from the date of issue.

 

The total Ordinary Shares to be issued pursuant to the Placing represent approximately 23.56% of the Company's existing issued share capital and will represent, in aggregate, approximately 19.07% of the Company's enlarged issued share capital.

 

Admission of the new Ordinary Shares to trading on AIM

 

Application will be made for admission of 29,636,364 new Ordinary Shares to be issued pursuant to the Placing to trading on the AIM Market of the London Stock Exchange, which is expected to take place on or around 8.00 a.m. on 10th May 2017 ("Admission"). The Placing is conditional on Admission becoming effective. The new Ordinary Shares will, when issued, be credited as fully paid and will rank equally in all respects with the existing Ordinary Shares, including the right to receive any dividend or other distribution declared, made or paid after Admission.

 

Following Admission, the Company's enlarged issued share capital will comprise 155,417,268 Ordinary Shares carrying one vote per share. The Company does not hold any Ordinary Shares in treasury.

 

 

 

Stuart Bladen, Chief Executive Officer of Falanx Group, commented:

 

 

"The cyber market is growing rapidly and it is important for Falanx to expand and take market share quickly to maximize our future value. We are therefore delighted to announce this placing which followed several approaches from interested investors. The Board agree it was in our shareholders' interest to serve market demand for equity in Falanx because it strengthens our capital reserves, accelerates our growth and completes our pathway to full profitability without interruption. "

 

 

Enquiries:

 

Falanx Group Limited

Stuart Bladen, Chief Executive Officer

 

www.falanx.com

 

SPARK Advisory Partners Limited

Nominated Adviser

Matt Davis / James Keeshan

 

+44 (0) 203 368 3551

 

Whitman Howard Limited

Broker

Nick Lovering / Francis North

+44 (0) 207 659 1234

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBGGDUCUGBGRS
Date   Source Headline
9th Dec 20222:42 pmRNSHolding(s) in Company
8th Dec 20224:29 pmRNSResult of AGM
8th Dec 20227:00 amRNSInterim Results
24th Nov 20225:17 pmRNSHolding(s) in Company
15th Nov 20225:56 pmRNSNotice of AGM
18th Oct 20227:00 amRNSDirectorate Change
29th Sep 20227:00 amRNSFinal Results
20th Sep 20227:00 amRNSHolding(s) in Company
5th Sep 20224:53 pmRNSHolding(s) in Company
4th Aug 20222:06 pmRNSSecond Price Monitoring Extn
4th Aug 20222:00 pmRNSPrice Monitoring Extension
4th Aug 202211:05 amRNSSecond Price Monitoring Extn
4th Aug 202211:00 amRNSPrice Monitoring Extension
4th Aug 20227:00 amRNSTrading Update
9th May 20227:00 amRNSPartnership to Provide M-EDR to UK Customers
8th Apr 20224:06 pmRNSHolding(s) in Company
6th Apr 202211:59 amRNSHolding(s) in Company
1st Apr 20227:00 amRNSChange of Adviser
30th Mar 20222:44 pmRNSDirector/PDMR Shareholding
23rd Mar 202212:59 pmRNSDirector/PDMR Shareholding
10th Feb 202211:11 amRNSDirector/PDMR Shareholding
24th Jan 20227:00 amRNSDirector/PDMR Shareholding
19th Jan 20225:20 pmRNSHolding(s) in Company
19th Jan 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 202111:14 amRNSResult of AGM
7th Dec 20217:00 amRNSInterim Results
16th Nov 20212:10 pmRNSNotice of AGM
29th Oct 20211:57 pmRNSExercise of Options, TVR and PDMR dealing
27th Oct 20219:03 amRNSDirector/PDMR Shareholding
26th Oct 20217:00 amRNSDirector/PDMR Shareholding
25th Oct 20213:25 pmRNSExercise of Options and TVR
13th Oct 202111:06 amRNSSecond Price Monitoring Extn
13th Oct 202111:00 amRNSPrice Monitoring Extension
13th Oct 20217:00 amRNSTrading update and BOOST&Co loan facility update
6th Oct 20214:41 pmRNSSecond Price Monitoring Extn
6th Oct 20214:35 pmRNSPrice Monitoring Extension
6th Oct 20212:43 pmRNSSale of Assynt for £4.6 million
4th Oct 20217:00 amRNSFalanx Launch Mass Market Security Assessment Tool
29th Sep 20217:00 amRNSAnnual results for the year ended 31 March 2021
18th Aug 20217:01 amRNSGrant of share options
18th Aug 20217:00 amRNSTrading Update & New Loan Facility
9th Jul 20219:07 amRNSHolding(s) in Company
29th Apr 20217:00 amRNSCancellation of unapproved Share Options
1st Apr 20217:00 amRNSIssue of Equity and TVR
26th Feb 20213:31 pmRNSResult of GM
10th Feb 20212:03 pmRNSPublication of Circular & Notice of GM
8th Feb 202111:05 amRNSSecond Price Monitoring Extn
8th Feb 202111:00 amRNSPrice Monitoring Extension
5th Feb 20217:00 amRNSContract Wins and Covid Business Interruption Loan
18th Jan 20212:06 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.